(Q38306666)

2 September 2017

title

Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions (English)

1 reference

2 September 2017

1 reference

1 reference

ovarian serous carcinoma

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Marika Crescenzi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Andrea Tinazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Thomas Giurici

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Francesca Simonato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Vincenza Guzzardo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Laura Ventura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Silvia Chiarelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Ambrogio Fassina

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

28 May 2014

1 reference

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

685-693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24888238%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

PDCD4 expression in thyroid neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Tumor-cell-derived microvesicles as carriers of molecular information in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Epithelial-mesenchymal transition in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Detection of microRNAs in archival cytology urine smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

PDCD4 inhibits the malignant phenotype of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Functional delivery of viral miRNAs via exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

7 January 2021

Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

7 January 2021

Survivin expression impacts prognostically on NSCLC but not SCLC

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

7 January 2021

Secreted monocytic miR-150 enhances targeted endothelial cell migration

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21442

7 January 2021